Position history for BAILLIE GIFFORD & CO's holdings in DENALI THERAPEUTICS INC
BAILLIE GIFFORD & CO holds 12.3M shares of DNLI (DENALI THERAPEUTICS INC), worth $203.3M as of 2025-Q4. The position was increased (++6.2% shares). DNLI represents 0.2% of BAILLIE GIFFORD & CO's portfolio.
Current Value
$203.3M
Current Shares
12.3M
Total Value Change
-$116.3M
Total Shares Change
-1.5M
Other major holders of DNLI: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 12.3M |
+6.2% |
| $203.3M |
| 0.2% |
| $16.41 |
39 |
| 2025-Q3 | Decreased | 11.6M | -3.0% | $168.3M | 0.1% | $14.52 | 0 |
| 2025-Q2 | Decreased | 12M | -1.1% | $167.3M | 0.1% | $14.10 | 0 |
| 2025-Q1 | Decreased | 12.1M | -1.8% | $164.4M | 0.1% | $14.78 | 0 |
| 2024-Q4 | Decreased | 12.3M | -7.7% | $251M | 0.2% | $20.24 | 0 |
| 2024-Q3 | Decreased | 13.3M | -3.0% | $388.8M | 0.3% | $29.43 | 0 |
| 2024-Q2 | Decreased | 13.8M | -2.0% | $319.6M | 0.2% | $23.22 | 0 |